ArticleEndocrine connections2018

Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus.

Metin Guclu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.